Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Early Yutiq Approval Gives EyePoint Two Ophthalmic Drugs To Launch In 2019

Oct 15 2018

• By Joseph Haas

Eye

Related Content

pSivida On Cusp Of Uveitis Filings As EU Licensing Deal Nears

Jun 14 2017

Alimera, pSivida win FDA nod for Iluvien, finally

Sep 29 2014

Deal Watch: Allogene Gets Pfizer's Off-The-Shelf CAR-T Program, $300m Series A Backing

Apr 03 2018

pSivida Moving Forward With Late-Stage Eye Drug

Dec 24 2015

Related Companies

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

Alimera Sciences Inc.

Bausch Health Companies Inc.

Allergan plc

Additional Topics

Approvals Commercial Business Strategies Ophthalmic BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.